Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
49.10
+1.43 (3.00%)
Nov 22, 2024, 4:00 PM EST - Market closed
Cytokinetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 3.22 | 7.53 | 7.59 | 70.43 | 55.83 | 26.87 | Upgrade
|
| Other Revenue | - | - | 87 | - | - | - | Upgrade
|
| Revenue | 3.22 | 7.53 | 94.59 | 70.43 | 55.83 | 26.87 | Upgrade
|
| Revenue Growth (YoY) | -58.81% | -92.04% | 34.30% | 26.15% | 107.79% | -14.71% | Upgrade
|
| Cost of Revenue | 330.76 | 330.12 | 240.81 | 159.94 | 96.95 | 86.13 | Upgrade
|
| Gross Profit | -327.54 | -322.59 | -146.23 | -89.51 | -41.12 | -59.26 | Upgrade
|
| Selling, General & Admin | 197.09 | 173.61 | 177.98 | 96.8 | 52.82 | 39.61 | Upgrade
|
| Operating Expenses | 197.09 | 173.61 | 177.98 | 96.8 | 52.82 | 39.61 | Upgrade
|
| Operating Income | -524.63 | -496.21 | -324.2 | -186.31 | -93.94 | -98.87 | Upgrade
|
| Interest Expense | -80.98 | -57.67 | -51.16 | -29.33 | -38.68 | -27.36 | Upgrade
|
| Interest & Investment Income | 44.11 | 27.63 | 11.34 | 0.33 | 5.33 | 4.54 | Upgrade
|
| Other Non Operating Income (Expenses) | -14.9 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -576.4 | -526.24 | -364.02 | -215.31 | -127.29 | -121.69 | Upgrade
|
| Other Unusual Items | - | - | -24.94 | - | - | - | Upgrade
|
| Pretax Income | -576.4 | -526.24 | -388.96 | -215.31 | -127.29 | -121.69 | Upgrade
|
| Net Income | -576.4 | -526.24 | -388.96 | -215.31 | -127.29 | -121.69 | Upgrade
|
| Net Income to Common | -576.4 | -526.24 | -388.96 | -215.31 | -127.29 | -121.69 | Upgrade
|
| Shares Outstanding (Basic) | 107 | 97 | 90 | 77 | 65 | 58 | Upgrade
|
| Shares Outstanding (Diluted) | 107 | 97 | 90 | 77 | 65 | 58 | Upgrade
|
| Shares Change (YoY) | 12.36% | 7.46% | 16.83% | 19.16% | 12.07% | 5.80% | Upgrade
|
| EPS (Basic) | -5.38 | -5.45 | -4.33 | -2.80 | -1.97 | -2.11 | Upgrade
|
| EPS (Diluted) | -5.38 | -5.45 | -4.33 | -2.80 | -1.97 | -2.11 | Upgrade
|
| Free Cash Flow | -407.05 | -415.75 | -310.85 | -191.39 | -2.11 | -93.53 | Upgrade
|
| Free Cash Flow Per Share | -3.80 | -4.31 | -3.46 | -2.49 | -0.03 | -1.62 | Upgrade
|
| Gross Margin | - | - | -154.59% | -127.09% | -73.66% | -220.55% | Upgrade
|
| Operating Margin | -16297.79% | -6589.71% | -342.75% | -264.54% | -168.27% | -367.97% | Upgrade
|
| Profit Margin | -17906.24% | -6988.63% | -411.21% | -305.72% | -228.00% | -452.93% | Upgrade
|
| Free Cash Flow Margin | -12645.23% | -5521.24% | -328.64% | -271.76% | -3.78% | -348.09% | Upgrade
|
| EBITDA | -511.14 | -484.31 | -318.39 | -184.04 | -92.11 | -97.57 | Upgrade
|
| EBITDA Margin | - | - | - | -261.31% | -164.99% | - | Upgrade
|
| D&A For EBITDA | 13.48 | 11.89 | 5.81 | 2.28 | 1.83 | 1.29 | Upgrade
|
| EBIT | -524.63 | -496.21 | -324.2 | -186.31 | -93.94 | -98.87 | Upgrade
|
| EBIT Margin | - | - | - | -264.54% | -168.27% | - | Upgrade
|
| Revenue as Reported | 3.22 | 7.53 | 94.59 | 70.43 | 55.83 | 26.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.